1.25 / AMA PRA Category 1 Credit(s)TM 1.25 / CE for Pharmacists (0.125 CEUs)
Provided by the American Gastroenterological Association (AGA) and AKH Inc., Advancing Knowledge in Healthcare in collaboration with Haymarket Medical Education (HME).
Supported by educational grants from Allergan, Inc., Ironwood Pharmaceuticals, Inc., and Salix Pharmaceuticals, Inc.
Irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC) make up the largest diagnostic subgroups in gastroenterology practices and account for some 12% of patients who present in primary care practices. Nevertheless, patients often suffer needlessly, due to both diagnostic delays and inappropriate management. In this enduring myCME™ Town Wall, the faculty demonstrate how clear communication, not only with the patient but also among the multidisciplinary interprofessional care team, can facilitate a positive diagnosis without the need for extensive testing and help ensure patients receive appropriate, evidence-based treatment in a timely manner. The discussion will include tips for a taking stepwise approach to diagnosis as well as an update on the current understanding of the shared pathobiologic mechanisms underlying IBS/CIC and promising new and emerging treatments.
Clinicians who manage IBS/CIC, including gastroenterologists, internal medicine and family medicine physicians, gynecologists, pharmacists, and nurse practitioners (NPs) and physician assistants (PAs) who work in gastroenterology, gynecology, or primary care settings
After completing the activity, the participant should be better able to:
Describe the pathophysiologic continuum of IBS/CIC, with a focus on the biopsychosocial elements underlying gut-brain interaction
Identify and diagnose IBS/CIC promptly and accurately without extraneous testing
Develop a comprehensive, evidence-based treatment plan, including appropriate use of new and emerging therapeutic agents
Incorporate shared decision-making practices in setting goals and devising treatment plans
Conflict Of Interest Disclosure Policies
In accordance with the ACCME’s Standards for Commercial Support of Continuing Medical Education, all faculty and planning partners must disclose any financial relationship(s) or other relationship(s) held within the past 12 months. The AGA Institute and AKH Inc., Advancing Knowledge in Healthcare will implement mechanisms to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.
Moderator Paul Doghramji, MD Senior family physician, Collegeville Family Practice Medical Director of Health Services, Ursinus College Collegeville, PA
Dr. Doghramji has no relevant financial relationships to disclose.
Faculty Presenters Lin Chang, MD Vice Chief, Vatche and Tamar Manoukian Division of Digestive Diseases David Geffen School of Medicine Los Angeles, CA
Dr. Chang has received consulting fees from Alnylam, Ardelyx, Arena, Bioamerica, Ironwood Pharmaceuticals, IM HealthSciences, Salix Pharmaceuticals, Synergy, and Ritter. She also receives a salary from Allergan.
Hannah L. Fitch, FNP-BC Collegeville Family Practice Collegeville, PA
Ms. Fitch has no relevant financial relationships to disclose.
Brian E. Lacy, PhD, MD, FACG Senior Associate Consultant Mayo Clinic Jacksonville, FL
Dr. Lacy has received consulting fees from Ironwood Pharmaceuticals, Salix, and Shire.
Anthony Lembo, MD Professor of Medicine Harvard Medical School Department of Medicine Division of Gastroenterology Beth Israel Deaconess Medical Center Boston, MA
Dr. Lembo has no relevant financial relationships to disclose.
Patient/Advocacy Group Ceciel T. Rooker President International Foundation for Gastrointestinal Disorders Mount Pleasant, SC
Dr. Rooker has no relevant financial relationships to disclose.
Pharmacy Content Reviewers and Disclosure Thomas A. Ullman, MD Professor, Gastroenterology and Chief, Division of Gastroenterology Department of Medicine Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY
Dr. Ullman receives consulting fees from Pfizer Inc.
Victor B. Hatcher, PhD Associate Dean and Director of CME Professor, Medicine and Biochemistry Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY
Dr. Hatcher has no relevant financial relationships to disclose.
Ms. Duffy has no relevant financial relationships to disclose.
Accredited Provider Disclosures
The AGA Institute, AKH Inc., Advancing Knowledge in Healthcare, and HME staff involved in the planning and content review of this activity have no relevant financial relationships to disclose.
AMA PRA Category 1 Credit(s)TM
The AGA Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AGA Institute designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditsTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Pharmacists
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 1.25 contact hours (0.125 CEUs). UAN 0077-9999-19-037-H04-P. Initial Release Date: 6/28/2019.
If you claim CE for Pharmacy credit, you will be prompted to include your National Association of Boards of Pharmacy (NABP) # and date/month of birth. This information must be included in order for you to receive credit.
Additional Credit Information
Physician Assistant Continuing Education AAPA accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.25 Category 1 Credits for completing this activity.
Nurse Practitioner Continuing Education AANPCP accepts certificates of participation for educational activities approved for AMA PRA Category 1 CreditTM from organizations accredited by ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Disclosure of Unlabeled Use
This CME/CE activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient's medical condition.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the AGA Institute, AKH Inc., HME, Allergan, Inc., Ironwood Pharmaceuticals, Inc., or Salix Pharmaceuticals. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
If you have any questions relating to the accreditation of this activity, please contact the AGA education department at email@example.com or 301-654-2055.
If you have any questions relating to the CE accreditation of this activity, please contact AKH Inc. at firstname.lastname@example.org.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.